MedPath

High-Intensity Training Following Lung Transplantation

Not Applicable
Completed
Conditions
Lung Transplant
Exercise Training
Registration Number
NCT03155074
Lead Sponsor
Oslo University Hospital
Brief Summary

The HILT study is a prospective, single-blinded, randomized controlled trial comparing a high-intensity exercise training intervention with usual care among adult lung transplant recipients. Patients randomized to the training intervention arm will undergo individually tailored high-intensity exercise training (80-95% of maximum heart rate) three hours per week for 20 weeks. Training will be conducted at local fitness centers on a one-on-one basis.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
54
Inclusion Criteria
  • Stable medical condition in the opinion of the enrolling investigator
  • Able and willing to give informed consent
Exclusion Criteria
  • Expected survival less than 12 months
  • Unable to complete a maximal exercise test on a treadmill until exhaustion
  • Language barrier that interferes with data collection

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Change in peak oxygen uptake0-20 weeks

Measured by cardiopulmonary exercise test

Secondary Outcome Measures
NameTimeMethod
Change in total body composition (fat, muscle and bone mass)0-20 weeks

Measured by dual-energy x-ray absorptiometry (DEXA)

Change in upper body strength0-20 weeks

Measured by maximum breast press

Change in forced expiratory volume in one second (FEV1)0-20 weeks

Measured by spirometry

Change in leg strength0-20 weeks

Measured by maximum leg press

Change submaximal exercise capacity0-20 weeks

Measured by 6-minute walk distance

Change in hand strength0-20 weeks

Measured by grip strength dynamometer

Change in health-related quality of life0-20 weeks

Measured by Short Form 36 (SF-36)

Trial Locations

Locations (1)

Oslo University Hospital

🇳🇴

Oslo, Norway

Oslo University Hospital
🇳🇴Oslo, Norway

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.